English

ENDRA Life Sciences Inc.

EDGAR

NDRA Registration statement (S-4) · filed 2026-10-02

54 filing records in this dataset, filed from 2016-11-21 to 2026-10-02. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2019 Q4 · USD

Exact inputs and evidence

Revenue: 0 USD Source
Revenue: 0 USD Source

Operating cash flow

-1.91 million USD

2019 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: -8588851 USD Source
Operating Cash Flow: -6681336 USD Source

Free cash flow

-1.95 million USD

2019 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: -8588851 USD Source
Operating Cash Flow: -6681336 USD Source
Capital Expenditure: 43595 USD Source
Capital Expenditure: 5238 USD Source

Cash and cash equivalents: 1.74 million USD 2026-06-30 Source
Exact value

1739943 USD
Long-term debt including current maturities: 0 USD 2024-12-31 Source
Exact value

0 USD
Shares outstanding: 1.5 million shares 2026-06-30 Source
Exact value

1499838 shares

Reported share-count change

99.34% · 747 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

752390 shares · 2025-06-30· Source
1499838 shares · 2026-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

0 USD

2019-01-01 – 2019-12-31

Exact inputs and evidence

Revenue: 0 USD · 2019-01-01 – 2019-03-31 Source
Revenue: 0 USD · 2019-04-01 – 2019-06-30 Source
Revenue: 0 USD · 2019-07-01 – 2019-09-30 Source
Revenue: 0 USD · 2019-01-01 – 2019-12-31 Source
Revenue: 0 USD · 2019-01-01 – 2019-09-30 Source

Net income

-5.92 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Net income: -1595959 USD · 2025-07-01 – 2025-09-30 Source
Net income: -7027410 USD · 2025-01-01 – 2025-12-31 Source
Net income: -3858201 USD · 2025-01-01 – 2025-09-30 Source
Net income: -1311433 USD · 2026-01-01 – 2026-03-31 Source
Net income: 159944 USD · 2026-04-01 – 2026-06-30 Source

Operating cash flow

-4.82 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: -3570847 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -2406844 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: -5182558 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -3570847 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -1119650 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -2047210 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: -1119650 USD · 2026-01-01 – 2026-03-31 Source

Capital expenditure

17.3 thousand USD

2025-01-01 – 2025-12-31

Exact inputs and evidence

Capital expenditure: 17280 USD · 2025-01-01 – 2025-03-31 Source
Capital expenditure: 17280 USD · 2025-01-01 – 2025-06-30 Source
Capital expenditure: 17280 USD · 2025-01-01 – 2025-03-31 Source
Capital expenditure: 17280 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 17280 USD · 2025-01-01 – 2025-06-30 Source
Capital expenditure: 17280 USD · 2025-01-01 – 2025-12-31 Source
Capital expenditure: 17280 USD · 2025-01-01 – 2025-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-02.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 5 of 11 periods available· newest 2020-12-31
Operating income: 10 of 11 periods available· newest 2025-12-31
Net income: 10 of 11 periods available· newest 2025-12-31
Operating cash flow: 10 of 11 periods available· newest 2025-12-31
Capital expenditure: 9 of 11 periods available· newest 2025-12-31
Total assets: 10 of 11 periods available· newest 2025-12-31
Total liabilities: 10 of 11 periods available· newest 2025-12-31
Current assets: 10 of 11 periods available· newest 2025-12-31
Current liabilities: 10 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 4 of 11 periods available· newest 2025-12-31
Long-term debt including current maturities: 4 of 11 periods available· newest 2024-12-31
Shares outstanding: 10 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
+USD 4.48 million

Prior period

−USD 11.51 million

2024-01-01 – 2024-12-31
Current period

−USD 7.03 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-7027410 − -11507947 = 4480537 USD

-11507947 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-7027410 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · ENDRA Life Sciences Inc. · 2025-12-31 ENDRA Life Sciences Inc. (edgar:1681682) Year-over-year change in Net income: 4480537 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T09:08:02Z Snapshot: 09dfde1c504b3c91cee9c54c068e25b4701c74f8c3c137589d4fed9cc74e5310 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681682?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -7027410 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681682/000119312526410883/ndra-20261001.htm#6968328 Filing: 000119312526410883 Input fundies:NetIncome: -11507947 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681682/000119312526410883/ndra-20261001.htm#6970070 Filing: 000119312526410883
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 2.22 million

Prior period

−USD 7.4 million

2024-01-01 – 2024-12-31
Current period

−USD 5.18 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-5182558 − -7400547 = 2217989 USD

-7400547 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-5182558 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · ENDRA Life Sciences Inc. · 2025-12-31 ENDRA Life Sciences Inc. (edgar:1681682) Year-over-year change in Operating cash flow: 2217989 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T09:08:02Z Snapshot: 09dfde1c504b3c91cee9c54c068e25b4701c74f8c3c137589d4fed9cc74e5310 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681682?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -5182558 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681682/000119312526410883/ndra-20261001.htm#7036865 Filing: 000119312526410883 Input fundies:OperatingCashFlow: -7400547 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681682/000119312526410883/ndra-20261001.htm#7038724 Filing: 000119312526410883
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+8%

Prior period

USD 16,000

2024-01-01 – 2024-12-31
Current period

USD 17,280

2025-01-01 – 2025-12-31

Exact inputs and evidence

17280 − 16000 = 1280 USD

16000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
17280 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · ENDRA Life Sciences Inc. · 2025-12-31 ENDRA Life Sciences Inc. (edgar:1681682) Year-over-year change in Capital expenditure: 1280 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T09:08:02Z Snapshot: 09dfde1c504b3c91cee9c54c068e25b4701c74f8c3c137589d4fed9cc74e5310 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681682?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 17280 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681682/000119312526410883/ndra-20261001.htm#7047597 Filing: 000119312526410883 Input fundies:CapitalExpenditure: 16000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681682/000119312526410883/ndra-20261001.htm#7049356 Filing: 000119312526410883
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2020 2020-01-01 – 2020-12-31

Revenue USD 0
Cost of revenue USD 0
Operating expenses USD 11.5 million
Other operating costs Derived USD 0
Operating income −USD 11.5 million
Tax, interest and other Derived USD 223,584
Net income −USD 11.73 million

Cash

Operating cash flow −USD 10.75 million
Capital expenditure USD 75,333
Free cash flow Derived −USD 10.82 million

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2016 Operating loss: operating costs were 448% of revenue.
2017 Operating loss: operating costs were 1,416% of revenue.
2018 Operating loss: operating costs were 146,180% of revenue.
2019 Not shown: operating income or net income is not reported.
2020 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2016 2016-01-01 – 2016-12-31	515582	2307340 Derived	-1791758	983610 Derived	-2775368	Unavailable	Source 2016-01-01 – 2016-12-31: 515582 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -1791758 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -2775368 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: -1315623 USD Inspect Operating Cash Flow Open source
2017 2017-01-01 – 2017-12-31	351622	4977680 Derived	-4626058	750904 Derived	-5376962	-3308775 Derived	Source 2017-01-01 – 2017-12-31: 351622 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -4626058 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -5376962 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -3300913 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 7862 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	6174	9025182 Derived	-9019008	777253 Derived	-9796261	-7802481 Derived	Source 2018-01-01 – 2018-12-31: 6174 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -9019008 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -9796261 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -7702481 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 100000 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	0	10843592 Derived	-10843592	2462372 Derived	-13305964	-8632446 Derived	Source 2019-01-01 – 2019-12-31: 0 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -10843592 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -13305964 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -8588851 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 43595 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	0	11501917 Derived	-11501917	223584 Derived	-11725501	-10821928 Derived	Source 2020-01-01 – 2020-12-31: 0 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -11501917 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -11725501 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -10746595 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 75333 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 0 2020

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Revenue	515582	Revenue: 515582 Open source
20172017-12-31	Revenue	351622	Revenue: 351622 Open source
20182018-12-31	Revenue	6174	Revenue: 6174 Open source
20192019-12-31	Revenue	0	Revenue: 0 Open source
20202020-12-31	Revenue	0	Revenue: 0 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-100% 2019

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Year over year	No prior comparable period	Revenue: 515582 Open source
20172017-12-31	Year over year	-31.8%	Revenue: 351622 Open source Revenue: 515582 Open source
20182018-12-31	Year over year	-98.2%	Revenue: 6174 Open source Revenue: 351622 Open source
20192019-12-31	Year over year	-100%	Revenue: 0 Open source Revenue: 6174 Open source
20202020-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -146,080.5% 2018

Net margin -158,669.6% 2018

Free cash flow margin -126,376.4% 2018

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Operating margin	-347.5%	Operating Income: -1791758 Open source Revenue: 515582 Open source
20172017-12-31	Operating margin	-1,315.6%	Operating Income: -4626058 Open source Revenue: 351622 Open source
20182018-12-31	Operating margin	-146,080.5%	Operating Income: -9019008 Open source Revenue: 6174 Open source
20192019-12-31	Operating margin	Not reported	Operating Income: -10843592 Open source Revenue: 0 Open source
20202020-12-31	Operating margin	Not reported	Operating Income: -11501917 Open source Revenue: 0 Open source
20162016-12-31	Net margin	-538.3%	Net Income: -2775368 Open source Revenue: 515582 Open source
20172017-12-31	Net margin	-1,529.2%	Net Income: -5376962 Open source Revenue: 351622 Open source
20182018-12-31	Net margin	-158,669.6%	Net Income: -9796261 Open source Revenue: 6174 Open source
20192019-12-31	Net margin	Not reported	Net Income: -13305964 Open source Revenue: 0 Open source
20202020-12-31	Net margin	Not reported	Net Income: -11725501 Open source Revenue: 0 Open source
20162016-12-31	Free cash flow margin	Not reported	Revenue: 515582 Open source Operating Cash Flow: -1315623 Open source
20172017-12-31	Free cash flow margin	-941%	Revenue: 351622 Open source Operating Cash Flow: -3300913 Open source Capital Expenditure: 7862 Open source
20182018-12-31	Free cash flow margin	-126,376.4%	Revenue: 6174 Open source Operating Cash Flow: -7702481 Open source Capital Expenditure: 100000 Open source
20192019-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -8588851 Open source Capital Expenditure: 43595 Open source
20202020-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -10746595 Open source Capital Expenditure: 75333 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -10.7M 2020

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Operating cash flow	-1315623	Operating Cash Flow: -1315623 Open source
20172017-12-31	Operating cash flow	-3300913	Operating Cash Flow: -3300913 Open source
20182018-12-31	Operating cash flow	-7702481	Operating Cash Flow: -7702481 Open source
20192019-12-31	Operating cash flow	-8588851	Operating Cash Flow: -8588851 Open source
20202020-12-31	Operating cash flow	-10746595	Operating Cash Flow: -10746595 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -10.8M 2020

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Free cash flow	Unavailable	Operating Cash Flow: -1315623 Open source
20172017-12-31	Free cash flow	-3308775	Operating Cash Flow: -3300913 Open source Capital Expenditure: 7862 Open source
20182018-12-31	Free cash flow	-7802481	Operating Cash Flow: -7702481 Open source Capital Expenditure: 100000 Open source
20192019-12-31	Free cash flow	-8632446	Operating Cash Flow: -8588851 Open source Capital Expenditure: 43595 Open source
20202020-12-31	Free cash flow	-10821928	Operating Cash Flow: -10746595 Open source Capital Expenditure: 75333 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

18.2% 2020

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Liabilities / assets	282.1%	Total Liabilities: 1384528 Open source Total Assets: 490761 Open source
20172017-12-31	Liabilities / assets	13.9%	Total Liabilities: 848214 Open source Total Assets: 6123702 Open source
20182018-12-31	Liabilities / assets	13.5%	Total Liabilities: 974583 Open source Total Assets: 7222791 Open source
20192019-12-31	Liabilities / assets	33.7%	Total Liabilities: 2415599 Open source Total Assets: 7176269 Open source
20202020-12-31	Liabilities / assets	18.2%	Total Liabilities: 1595655 Open source Total Assets: 8764976 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

8.32× 2020

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Current assets / current liabilities	0.14×	Current Assets: 195593 Open source Current Liabilities: 1384528 Open source
20172017-12-31	Current assets / current liabilities	6.93×	Current Assets: 5882153 Open source Current Liabilities: 848214 Open source
20182018-12-31	Current assets / current liabilities	7.13×	Current Assets: 6949558 Open source Current Liabilities: 974583 Open source
20192019-12-31	Current assets / current liabilities	3.15×	Current Assets: 6535099 Open source Current Liabilities: 2072787 Open source
20202020-12-31	Current assets / current liabilities	8.32×	Current Assets: 8207736 Open source Current Liabilities: 986663 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2016 2016-01-01 – 2016-12-31	−USD 2.78 million Exact value Exact value: -2775368 USD 2016-01-01 – 2016-12-31: -2775368 USD Inspect Net Income Open source Share or cite Citation for Net Income · ENDRA Life Sciences Inc. · 2016-12-31 ENDRA Life Sciences Inc. (edgar:1681682) Net Income: -2775368 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T09:08:02Z Snapshot: 09dfde1c504b3c91cee9c54c068e25b4701c74f8c3c137589d4fed9cc74e5310 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681682/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2775368 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681682/000165495418002829/ndrau-20171231.xml#31101 Filing: 000165495418002829 The citation records this snapshot. The page link may show a newer release later.	−USD 1.32 million Exact value Exact value: -1315623 USD 2016-01-01 – 2016-12-31: -1315623 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ENDRA Life Sciences Inc. · 2016-12-31 ENDRA Life Sciences Inc. (edgar:1681682) Operating Cash Flow: -1315623 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T09:08:02Z Snapshot: 09dfde1c504b3c91cee9c54c068e25b4701c74f8c3c137589d4fed9cc74e5310 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681682/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1315623 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681682/000165495418002829/ndrau-20171231.xml#35664 Filing: 000165495418002829 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2017 2017-01-01 – 2017-12-31	−USD 5.38 million Exact value Exact value: -5376962 USD 2017-01-01 – 2017-12-31: -5376962 USD Inspect Net Income Open source Share or cite Citation for Net Income · ENDRA Life Sciences Inc. · 2017-12-31 ENDRA Life Sciences Inc. (edgar:1681682) Net Income: -5376962 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T09:08:02Z Snapshot: 09dfde1c504b3c91cee9c54c068e25b4701c74f8c3c137589d4fed9cc74e5310 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681682/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -5376962 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681682/000165495419002560/ndrau-20181231.xml#38500 Filing: 000165495419002560 The citation records this snapshot. The page link may show a newer release later.	−USD 3.3 million Exact value Exact value: -3300913 USD 2017-01-01 – 2017-12-31: -3300913 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ENDRA Life Sciences Inc. · 2017-12-31 ENDRA Life Sciences Inc. (edgar:1681682) Operating Cash Flow: -3300913 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T09:08:02Z Snapshot: 09dfde1c504b3c91cee9c54c068e25b4701c74f8c3c137589d4fed9cc74e5310 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681682/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3300913 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681682/000165495419002560/ndrau-20181231.xml#42096 Filing: 000165495419002560 The citation records this snapshot. The page link may show a newer release later.	USD 7,862 Exact value Exact value: 7862 USD 2017-01-01 – 2017-12-31: 7862 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ENDRA Life Sciences Inc. · 2017-12-31 ENDRA Life Sciences Inc. (edgar:1681682) Capital Expenditure: 7862 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T09:08:02Z Snapshot: 09dfde1c504b3c91cee9c54c068e25b4701c74f8c3c137589d4fed9cc74e5310 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681682/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 7862 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681682/000165495419002560/ndrau-20181231.xml#55734 Filing: 000165495419002560 The citation records this snapshot. The page link may show a newer release later.	−USD 3.31 million Calculation and evidence -3300913 − 7862 USD Exact free cash flow: -3308775 USD 2017-01-01 – 2017-12-31: -3300913 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 7862 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ENDRA Life Sciences Inc. · 2017-12-31 ENDRA Life Sciences Inc. (edgar:1681682) Free cash flow: -3308775 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T09:08:02Z Snapshot: 09dfde1c504b3c91cee9c54c068e25b4701c74f8c3c137589d4fed9cc74e5310 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681682?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3300913 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681682/000165495419002560/ndrau-20181231.xml#42096 Filing: 000165495419002560 Input fundies:CapitalExpenditure: 7862 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681682/000165495419002560/ndrau-20181231.xml#55734 Filing: 000165495419002560 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 9.8 million Exact value Exact value: -9796261 USD 2018-01-01 – 2018-12-31: -9796261 USD Inspect Net Income Open source Share or cite Citation for Net Income · ENDRA Life Sciences Inc. · 2018-12-31 ENDRA Life Sciences Inc. (edgar:1681682) Net Income: -9796261 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T09:08:02Z Snapshot: 09dfde1c504b3c91cee9c54c068e25b4701c74f8c3c137589d4fed9cc74e5310 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681682/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -9796261 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681682/000165495420003346/ndrau-20191231.xml#42239 Filing: 000165495420003346 The citation records this snapshot. The page link may show a newer release later.	−USD 7.7 million Exact value Exact value: -7702481 USD 2018-01-01 – 2018-12-31: -7702481 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ENDRA Life Sciences Inc. · 2018-12-31 ENDRA Life Sciences Inc. (edgar:1681682) Operating Cash Flow: -7702481 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T09:08:02Z Snapshot: 09dfde1c504b3c91cee9c54c068e25b4701c74f8c3c137589d4fed9cc74e5310 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681682/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7702481 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681682/000165495420003346/ndrau-20191231.xml#54860 Filing: 000165495420003346 The citation records this snapshot. The page link may show a newer release later.	USD 100,000 Exact value Exact value: 100000 USD 2018-01-01 – 2018-12-31: 100000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ENDRA Life Sciences Inc. · 2018-12-31 ENDRA Life Sciences Inc. (edgar:1681682) Capital Expenditure: 100000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T09:08:02Z Snapshot: 09dfde1c504b3c91cee9c54c068e25b4701c74f8c3c137589d4fed9cc74e5310 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681682/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 100000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681682/000165495420003346/ndrau-20191231.xml#55227 Filing: 000165495420003346 The citation records this snapshot. The page link may show a newer release later.	−USD 7.8 million Calculation and evidence -7702481 − 100000 USD Exact free cash flow: -7802481 USD 2018-01-01 – 2018-12-31: -7702481 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 100000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ENDRA Life Sciences Inc. · 2018-12-31 ENDRA Life Sciences Inc. (edgar:1681682) Free cash flow: -7802481 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T09:08:02Z Snapshot: 09dfde1c504b3c91cee9c54c068e25b4701c74f8c3c137589d4fed9cc74e5310 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681682?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7702481 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681682/000165495420003346/ndrau-20191231.xml#54860 Filing: 000165495420003346 Input fundies:CapitalExpenditure: 100000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681682/000165495420003346/ndrau-20191231.xml#55227 Filing: 000165495420003346 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 13.31 million Exact value Exact value: -13305964 USD 2019-01-01 – 2019-12-31: -13305964 USD Inspect Net Income Open source Share or cite Citation for Net Income · ENDRA Life Sciences Inc. · 2019-12-31 ENDRA Life Sciences Inc. (edgar:1681682) Net Income: -13305964 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T09:08:02Z Snapshot: 09dfde1c504b3c91cee9c54c068e25b4701c74f8c3c137589d4fed9cc74e5310 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681682/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -13305964 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681682/000165495421003302/ndra-20201231.xml#58436 Filing: 000165495421003302 The citation records this snapshot. The page link may show a newer release later.	−USD 8.59 million Exact value Exact value: -8588851 USD 2019-01-01 – 2019-12-31: -8588851 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ENDRA Life Sciences Inc. · 2019-12-31 ENDRA Life Sciences Inc. (edgar:1681682) Operating Cash Flow: -8588851 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T09:08:02Z Snapshot: 09dfde1c504b3c91cee9c54c068e25b4701c74f8c3c137589d4fed9cc74e5310 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681682/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -8588851 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681682/000165495421003302/ndra-20201231.xml#63374 Filing: 000165495421003302 The citation records this snapshot. The page link may show a newer release later.	USD 43,595 Exact value Exact value: 43595 USD 2019-01-01 – 2019-12-31: 43595 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ENDRA Life Sciences Inc. · 2019-12-31 ENDRA Life Sciences Inc. (edgar:1681682) Capital Expenditure: 43595 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T09:08:02Z Snapshot: 09dfde1c504b3c91cee9c54c068e25b4701c74f8c3c137589d4fed9cc74e5310 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681682/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 43595 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681682/000165495421003302/ndra-20201231.xml#63741 Filing: 000165495421003302 The citation records this snapshot. The page link may show a newer release later.	−USD 8.63 million Calculation and evidence -8588851 − 43595 USD Exact free cash flow: -8632446 USD 2019-01-01 – 2019-12-31: -8588851 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 43595 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ENDRA Life Sciences Inc. · 2019-12-31 ENDRA Life Sciences Inc. (edgar:1681682) Free cash flow: -8632446 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T09:08:02Z Snapshot: 09dfde1c504b3c91cee9c54c068e25b4701c74f8c3c137589d4fed9cc74e5310 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681682?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -8588851 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681682/000165495421003302/ndra-20201231.xml#63374 Filing: 000165495421003302 Input fundies:CapitalExpenditure: 43595 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681682/000165495421003302/ndra-20201231.xml#63741 Filing: 000165495421003302 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 11.73 million Exact value Exact value: -11725501 USD 2020-01-01 – 2020-12-31: -11725501 USD Inspect Net Income Open source Share or cite Citation for Net Income · ENDRA Life Sciences Inc. · 2020-12-31 ENDRA Life Sciences Inc. (edgar:1681682) Net Income: -11725501 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T09:08:02Z Snapshot: 09dfde1c504b3c91cee9c54c068e25b4701c74f8c3c137589d4fed9cc74e5310 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681682/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -11725501 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681682/000165495422004172/ndra_10k.htm#703252 Filing: 000165495422004172 The citation records this snapshot. The page link may show a newer release later.	−USD 10.75 million Exact value Exact value: -10746595 USD 2020-01-01 – 2020-12-31: -10746595 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ENDRA Life Sciences Inc. · 2020-12-31 ENDRA Life Sciences Inc. (edgar:1681682) Operating Cash Flow: -10746595 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T09:08:02Z Snapshot: 09dfde1c504b3c91cee9c54c068e25b4701c74f8c3c137589d4fed9cc74e5310 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681682/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -10746595 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681682/000165495422004172/ndra_10k.htm#820476 Filing: 000165495422004172 The citation records this snapshot. The page link may show a newer release later.	USD 75,333 Exact value Exact value: 75333 USD 2020-01-01 – 2020-12-31: 75333 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ENDRA Life Sciences Inc. · 2020-12-31 ENDRA Life Sciences Inc. (edgar:1681682) Capital Expenditure: 75333 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T09:08:02Z Snapshot: 09dfde1c504b3c91cee9c54c068e25b4701c74f8c3c137589d4fed9cc74e5310 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681682/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 75333 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681682/000165495422004172/ndra_10k.htm#824314 Filing: 000165495422004172 The citation records this snapshot. The page link may show a newer release later.	−USD 10.82 million Calculation and evidence -10746595 − 75333 USD Exact free cash flow: -10821928 USD 2020-01-01 – 2020-12-31: -10746595 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 75333 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ENDRA Life Sciences Inc. · 2020-12-31 ENDRA Life Sciences Inc. (edgar:1681682) Free cash flow: -10821928 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T09:08:02Z Snapshot: 09dfde1c504b3c91cee9c54c068e25b4701c74f8c3c137589d4fed9cc74e5310 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681682?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -10746595 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681682/000165495422004172/ndra_10k.htm#820476 Filing: 000165495422004172 Input fundies:CapitalExpenditure: 75333 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681682/000165495422004172/ndra_10k.htm#824314 Filing: 000165495422004172 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 11.23 million Exact value Exact value: -11231250 USD 2021-01-01 – 2021-12-31: -11231250 USD Inspect Net Income Open source Share or cite Citation for Net Income · ENDRA Life Sciences Inc. · 2021-12-31 ENDRA Life Sciences Inc. (edgar:1681682) Net Income: -11231250 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T09:08:02Z Snapshot: 09dfde1c504b3c91cee9c54c068e25b4701c74f8c3c137589d4fed9cc74e5310 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681682/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -11231250 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681682/000165495423003044/ndra_10k.htm#706001 Filing: 000165495423003044 The citation records this snapshot. The page link may show a newer release later.	−USD 11.12 million Exact value Exact value: -11122384 USD 2021-01-01 – 2021-12-31: -11122384 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ENDRA Life Sciences Inc. · 2021-12-31 ENDRA Life Sciences Inc. (edgar:1681682) Operating Cash Flow: -11122384 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T09:08:02Z Snapshot: 09dfde1c504b3c91cee9c54c068e25b4701c74f8c3c137589d4fed9cc74e5310 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681682/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -11122384 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681682/000165495423003044/ndra_10k.htm#783922 Filing: 000165495423003044 The citation records this snapshot. The page link may show a newer release later.	USD 45,000 Exact value Exact value: 45000 USD 2021-01-01 – 2021-12-31: 45000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ENDRA Life Sciences Inc. · 2021-12-31 ENDRA Life Sciences Inc. (edgar:1681682) Capital Expenditure: 45000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T09:08:02Z Snapshot: 09dfde1c504b3c91cee9c54c068e25b4701c74f8c3c137589d4fed9cc74e5310 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681682/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 45000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681682/000165495423003044/ndra_10k.htm#787757 Filing: 000165495423003044 The citation records this snapshot. The page link may show a newer release later.	−USD 11.17 million Calculation and evidence -11122384 − 45000 USD Exact free cash flow: -11167384 USD 2021-01-01 – 2021-12-31: -11122384 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 45000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ENDRA Life Sciences Inc. · 2021-12-31 ENDRA Life Sciences Inc. (edgar:1681682) Free cash flow: -11167384 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T09:08:02Z Snapshot: 09dfde1c504b3c91cee9c54c068e25b4701c74f8c3c137589d4fed9cc74e5310 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681682?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -11122384 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681682/000165495423003044/ndra_10k.htm#783922 Filing: 000165495423003044 Input fundies:CapitalExpenditure: 45000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681682/000165495423003044/ndra_10k.htm#787757 Filing: 000165495423003044 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 13.18 million Exact value Exact value: -13179092 USD 2022-01-01 – 2022-12-31: -13179092 USD Inspect Net Income Open source Share or cite Citation for Net Income · ENDRA Life Sciences Inc. · 2022-12-31 ENDRA Life Sciences Inc. (edgar:1681682) Net Income: -13179092 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T09:08:02Z Snapshot: 09dfde1c504b3c91cee9c54c068e25b4701c74f8c3c137589d4fed9cc74e5310 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681682/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -13179092 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681682/000165495424003873/ndra_10k.htm#745278 Filing: 000165495424003873 The citation records this snapshot. The page link may show a newer release later.	−USD 12.77 million Exact value Exact value: -12769371 USD 2022-01-01 – 2022-12-31: -12769371 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ENDRA Life Sciences Inc. · 2022-12-31 ENDRA Life Sciences Inc. (edgar:1681682) Operating Cash Flow: -12769371 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T09:08:02Z Snapshot: 09dfde1c504b3c91cee9c54c068e25b4701c74f8c3c137589d4fed9cc74e5310 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681682/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -12769371 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681682/000165495424003873/ndra_10k.htm#762474 Filing: 000165495424003873 The citation records this snapshot. The page link may show a newer release later.	USD 202,577 Exact value Exact value: 202577 USD 2022-01-01 – 2022-12-31: 202577 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ENDRA Life Sciences Inc. · 2022-12-31 ENDRA Life Sciences Inc. (edgar:1681682) Capital Expenditure: 202577 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T09:08:02Z Snapshot: 09dfde1c504b3c91cee9c54c068e25b4701c74f8c3c137589d4fed9cc74e5310 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681682/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 202577 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681682/000165495424003873/ndra_10k.htm#766194 Filing: 000165495424003873 The citation records this snapshot. The page link may show a newer release later.	−USD 12.97 million Calculation and evidence -12769371 − 202577 USD Exact free cash flow: -12971948 USD 2022-01-01 – 2022-12-31: -12769371 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 202577 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ENDRA Life Sciences Inc. · 2022-12-31 ENDRA Life Sciences Inc. (edgar:1681682) Free cash flow: -12971948 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T09:08:02Z Snapshot: 09dfde1c504b3c91cee9c54c068e25b4701c74f8c3c137589d4fed9cc74e5310 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681682?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -12769371 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681682/000165495424003873/ndra_10k.htm#762474 Filing: 000165495424003873 Input fundies:CapitalExpenditure: 202577 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681682/000165495424003873/ndra_10k.htm#766194 Filing: 000165495424003873 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 10.06 million Exact value Exact value: -10060250 USD 2023-01-01 – 2023-12-31: -10060250 USD Inspect Net Income Open source Share or cite Citation for Net Income · ENDRA Life Sciences Inc. · 2023-12-31 ENDRA Life Sciences Inc. (edgar:1681682) Net Income: -10060250 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T09:08:02Z Snapshot: 09dfde1c504b3c91cee9c54c068e25b4701c74f8c3c137589d4fed9cc74e5310 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681682/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -10060250 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681682/000165495425003937/endra_10k.htm#344277 Filing: 000165495425003937 The citation records this snapshot. The page link may show a newer release later.	−USD 9.55 million Exact value Exact value: -9548775 USD 2023-01-01 – 2023-12-31: -9548775 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ENDRA Life Sciences Inc. · 2023-12-31 ENDRA Life Sciences Inc. (edgar:1681682) Operating Cash Flow: -9548775 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T09:08:02Z Snapshot: 09dfde1c504b3c91cee9c54c068e25b4701c74f8c3c137589d4fed9cc74e5310 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681682/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9548775 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681682/000165495425003937/endra_10k.htm#365330 Filing: 000165495425003937 The citation records this snapshot. The page link may show a newer release later.	USD 33,884 Exact value Exact value: 33884 USD 2023-01-01 – 2023-12-31: 33884 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ENDRA Life Sciences Inc. · 2023-12-31 ENDRA Life Sciences Inc. (edgar:1681682) Capital Expenditure: 33884 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T09:08:02Z Snapshot: 09dfde1c504b3c91cee9c54c068e25b4701c74f8c3c137589d4fed9cc74e5310 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681682/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 33884 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681682/000165495425003937/endra_10k.htm#369045 Filing: 000165495425003937 The citation records this snapshot. The page link may show a newer release later.	−USD 9.58 million Calculation and evidence -9548775 − 33884 USD Exact free cash flow: -9582659 USD 2023-01-01 – 2023-12-31: -9548775 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 33884 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ENDRA Life Sciences Inc. · 2023-12-31 ENDRA Life Sciences Inc. (edgar:1681682) Free cash flow: -9582659 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T09:08:02Z Snapshot: 09dfde1c504b3c91cee9c54c068e25b4701c74f8c3c137589d4fed9cc74e5310 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681682?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -9548775 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681682/000165495425003937/endra_10k.htm#365330 Filing: 000165495425003937 Input fundies:CapitalExpenditure: 33884 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681682/000165495425003937/endra_10k.htm#369045 Filing: 000165495425003937 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 11.51 million Exact value Exact value: -11507947 USD 2024-01-01 – 2024-12-31: -11507947 USD Inspect Net Income Open source Share or cite Citation for Net Income · ENDRA Life Sciences Inc. · 2024-12-31 ENDRA Life Sciences Inc. (edgar:1681682) Net Income: -11507947 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T09:08:02Z Snapshot: 09dfde1c504b3c91cee9c54c068e25b4701c74f8c3c137589d4fed9cc74e5310 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681682/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -11507947 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681682/000119312526410883/ndra-20261001.htm#6970070 Filing: 000119312526410883 The citation records this snapshot. The page link may show a newer release later.	−USD 7.4 million Exact value Exact value: -7400547 USD 2024-01-01 – 2024-12-31: -7400547 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ENDRA Life Sciences Inc. · 2024-12-31 ENDRA Life Sciences Inc. (edgar:1681682) Operating Cash Flow: -7400547 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T09:08:02Z Snapshot: 09dfde1c504b3c91cee9c54c068e25b4701c74f8c3c137589d4fed9cc74e5310 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681682/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7400547 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681682/000119312526410883/ndra-20261001.htm#7038724 Filing: 000119312526410883 The citation records this snapshot. The page link may show a newer release later.	USD 16,000 Exact value Exact value: 16000 USD 2024-01-01 – 2024-12-31: 16000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ENDRA Life Sciences Inc. · 2024-12-31 ENDRA Life Sciences Inc. (edgar:1681682) Capital Expenditure: 16000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T09:08:02Z Snapshot: 09dfde1c504b3c91cee9c54c068e25b4701c74f8c3c137589d4fed9cc74e5310 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681682/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 16000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681682/000119312526410883/ndra-20261001.htm#7049356 Filing: 000119312526410883 The citation records this snapshot. The page link may show a newer release later.	−USD 7.42 million Calculation and evidence -7400547 − 16000 USD Exact free cash flow: -7416547 USD 2024-01-01 – 2024-12-31: -7400547 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 16000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ENDRA Life Sciences Inc. · 2024-12-31 ENDRA Life Sciences Inc. (edgar:1681682) Free cash flow: -7416547 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T09:08:02Z Snapshot: 09dfde1c504b3c91cee9c54c068e25b4701c74f8c3c137589d4fed9cc74e5310 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681682?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7400547 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681682/000119312526410883/ndra-20261001.htm#7038724 Filing: 000119312526410883 Input fundies:CapitalExpenditure: 16000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681682/000119312526410883/ndra-20261001.htm#7049356 Filing: 000119312526410883 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	−USD 7.03 million Exact value Exact value: -7027410 USD 2025-01-01 – 2025-12-31: -7027410 USD Inspect Net Income Open source Share or cite Citation for Net Income · ENDRA Life Sciences Inc. · 2025-12-31 ENDRA Life Sciences Inc. (edgar:1681682) Net Income: -7027410 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T09:08:02Z Snapshot: 09dfde1c504b3c91cee9c54c068e25b4701c74f8c3c137589d4fed9cc74e5310 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681682/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -7027410 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681682/000119312526410883/ndra-20261001.htm#6968328 Filing: 000119312526410883 The citation records this snapshot. The page link may show a newer release later.	−USD 5.18 million Exact value Exact value: -5182558 USD 2025-01-01 – 2025-12-31: -5182558 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ENDRA Life Sciences Inc. · 2025-12-31 ENDRA Life Sciences Inc. (edgar:1681682) Operating Cash Flow: -5182558 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T09:08:02Z Snapshot: 09dfde1c504b3c91cee9c54c068e25b4701c74f8c3c137589d4fed9cc74e5310 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681682/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5182558 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681682/000119312526410883/ndra-20261001.htm#7036865 Filing: 000119312526410883 The citation records this snapshot. The page link may show a newer release later.	USD 17,280 Exact value Exact value: 17280 USD 2025-01-01 – 2025-12-31: 17280 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ENDRA Life Sciences Inc. · 2025-12-31 ENDRA Life Sciences Inc. (edgar:1681682) Capital Expenditure: 17280 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T09:08:02Z Snapshot: 09dfde1c504b3c91cee9c54c068e25b4701c74f8c3c137589d4fed9cc74e5310 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681682/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 17280 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681682/000119312526410883/ndra-20261001.htm#7047597 Filing: 000119312526410883 The citation records this snapshot. The page link may show a newer release later.	−USD 5.2 million Calculation and evidence -5182558 − 17280 USD Exact free cash flow: -5199838 USD 2025-01-01 – 2025-12-31: -5182558 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 17280 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ENDRA Life Sciences Inc. · 2025-12-31 ENDRA Life Sciences Inc. (edgar:1681682) Free cash flow: -5199838 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T09:08:02Z Snapshot: 09dfde1c504b3c91cee9c54c068e25b4701c74f8c3c137589d4fed9cc74e5310 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1681682?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -5182558 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681682/000119312526410883/ndra-20261001.htm#7036865 Filing: 000119312526410883 Input fundies:CapitalExpenditure: 17280 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1681682/000119312526410883/ndra-20261001.htm#7047597 Filing: 000119312526410883 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

54 filings · 2,289 latest values · 2,289 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001681682, 1681682, NDRA, edgar:1681682

Also known as ENDRA LIFE SCIENCES INC, ENDRA LIFE SCIENCES INC., ENDRA Life Sciences Inc., Endra Inc.

ENDRA Life Sciences Inc.

Latest quarter

Revenue

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2020 2020-01-01 – 2020-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation